lenalidomide
UkraineDrugs containing this active substance
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Reliance Life Sciences Private Limited (Plant 6)
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Reliance Life Sciences Private Limited (Plant 6)
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Reliance Life Sciences Private Limited (Plant 6)
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Reliance Life Sciences Private Limited (Plant 6)
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Reliance Life Sciences Private Limited (Plant 6)
-
The drug is used to treat adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Reliance Life Sciences Private Limited (Plant 6)
-
The drug is used to treat adult patients with multiple myeloma, myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Synthon Hispania, S.L. (packaging, quality control, batch release unit)
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Synthon Hispania, S.L. (packaging, quality control, batch release unit)
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Synthon Hispania, S.L. (packaging, quality control, batch release unit)
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Synthon Hispania, S.L. (packaging, quality control, batch release unit)
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Synthon Hispania, S.L. (packaging, quality control, batch release unit)
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Synthon Hispania, S.L. (packaging, quality control, batch release unit)
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndrome (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Synthon Hispania, S.L. (packaging, quality control, batch release unit)
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Hetero Labs Limited
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Hetero Labs Limited
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Hetero Labs Limited